Additional requirements for complex interventions

descriptionPublicationkeyboard_double_arrow_right Article 26 Nov 2012 English Publisher:BMJJournal:BMJ, volume 345, pages e8003-e8003 (eissn: 1756-1833,

Copyright policy )

Authors: Thees F, Spreckelsen; Sean P, Grant; Paul, Montgomery;

doi: 10.1136/bmj.e8003

pmid: 23183069

Additional requirements for complex interventions

- Summary
- Subjects
- Metrics

Abstract

Similar to drug companies, developers of complex interventions are also liable to conflicts of interest that may bias results. We thus support the BMJ ’s decision to “publish only where there is a commitment to make the relevant anonymised patient level data available on reasonable request,”1 and we make suggestions that apply …

Related Organizations

University of Oxford
United Kingdom

Keywords

Access to Information, Clinical Trials as Topic, Pharmaceutical Preparations, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average